Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Laurus Labs has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, January 24, 2024, to consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023. Further, the Company’s trading window for dealing in securities by the Directors and Designated Persons has been closed from Monday, January 01, 2024, which was already intimated on December 27, 2023, and shall continue to remain closed till Friday, January 26, 2024.
The above information is a part of company’s filings submitted to BSE.
